Studies have shown that KBI-092 exhibits potent inhibitory activity against this protein, with an IC50 value of <10 nM. This high level of potency and selectivity makes KBI-092 an attractive therapeutic candidate for the treatment of inflammatory diseases.
The potential applications of KBI-092 are vast, with possible uses in a range of inflammatory diseases, including: KBI-092